Show simple item record

DRUG RETENTION RATE AND PROGNOSIS AFTER DISCONTINUATION OF INFLIXIMAB IN PATIENTS WITH BEHCET SYNDROME

dc.contributor.authorTaflan, S. S.
dc.contributor.authorOzyazgan, Y.
dc.contributor.authorUcar, D.
dc.contributor.authorSeyahi, E.
dc.contributor.authorMelikoglu, M.
dc.contributor.authorHamuryudan, V.
dc.contributor.authorHatemi, G.
dc.contributor.authorYurdakul, S.
dc.contributor.authorFresko, I.
dc.contributor.authorSİVA, Aksel
dc.contributor.authorUygunoglu, U.
dc.contributor.authorYazici, H.
dc.contributor.authorEsatoglu, S. N.
dc.contributor.authorTukek, B.
dc.date.accessioned2021-03-02T18:14:47Z
dc.date.available2021-03-02T18:14:47Z
dc.identifier.citationEsatoglu S. N. , Tukek B., Taflan S. S. , Ozyazgan Y., Ucar D., Seyahi E., Melikoglu M., Hamuryudan V., Uygunoglu U., SİVA A., et al., "DRUG RETENTION RATE AND PROGNOSIS AFTER DISCONTINUATION OF INFLIXIMAB IN PATIENTS WITH BEHCET SYNDROME", Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1067-1068
dc.identifier.otherav_e1e948dd-0d39-4e11-aeb3-dc97afceacdf
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/4765
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2020-eular.3299
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectİmmünoloji ve Romatoloji
dc.subjectROMATOLOJİ
dc.subjectKlinik Tıp (MED)
dc.titleDRUG RETENTION RATE AND PROGNOSIS AFTER DISCONTINUATION OF INFLIXIMAB IN PATIENTS WITH BEHCET SYNDROME
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume79
dc.contributor.firstauthorID2282104


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record